Natures Sunshine Products

Nature's Sunshine Products, a Pharmaceutical Preparation Manufacturing company based in the US, reported approximately 44,047,000 kg CO2e in total greenhouse gas emissions for 2023. This total comprises Scope 1 emissions of around 1,071,900 kg CO2e, Scope 2 emissions of approximately 1,128,100 kg CO2e, and Scope 3 emissions of about 41,843,000 kg CO2e. Key contributors to Scope 3 emissions included purchased goods and services at approximately 36,070,000 kg CO2e, and downstream transportation and distribution at around 3,689,000 kg CO2e.

In 2022, the company's Scope 1 emissions were approximately 1,750,000 kg CO2e, and Scope 2 emissions were about 936,300 kg CO2e. In 2021, Nature's Sunshine Products reported Scope 1 emissions of roughly 1,750,000 kg CO2e and Scope 2 emissions of approximately 1,750,000 kg CO2e. Scope 3 emissions data was not disclosed for 2021. The company has not publicly set any specific reduction targets, including SBTi validated targets or a Climate Pledge. All reported data is directly from Nature's Sunshine Products, Inc.